AAAAAA

   
Results: 1-10 |
Results: 10
Mutant huntingtin enhances excitotoxic cell death
Authors: Zeron, MM Chen, NS Moshaver, A Lee, ATC Wellington, CL Hayden, MR Raymond, LA
Citation: Mm. Zeron et al., Mutant huntingtin enhances excitotoxic cell death, MOL CELL NE, 17(1), 2001, pp. 41-53
Human ABCA1 BAC transgenic mice show increased high density lipoprotein cholesterol and apoAI-dependent efflux stimulated by an internal promoter containing liver X receptor response elements in intron 1
Authors: Singaraja, RR Bocher, V James, ER Clee, SM Zhang, LH Leavitt, BR Tan, B Brooks-Wilson, A Kwok, A Bissada, N Yang, YZ Liu, GQ Tafuri, SR Fievet, C Wellington, CL Staels, B Hayden, MR
Citation: Rr. Singaraja et al., Human ABCA1 BAC transgenic mice show increased high density lipoprotein cholesterol and apoAI-dependent efflux stimulated by an internal promoter containing liver X receptor response elements in intron 1, J BIOL CHEM, 276(36), 2001, pp. 33969-33979
Huntington disease: new insights on the role of huntingtin cleavage
Authors: Wellington, CL Leavitt, BR Hayden, MR
Citation: Cl. Wellington et al., Huntington disease: new insights on the role of huntingtin cleavage, J NEUR TR-S, (58), 2000, pp. 1-17
Recent insights into the molecular pathogenesis of Huntington disease (vol19, pg 385, 1999)
Authors: Leavitt, BR Wellington, CL Hayden, MR
Citation: Br. Leavitt et al., Recent insights into the molecular pathogenesis of Huntington disease (vol19, pg 385, 1999), SEM NEUROL, 20(2), 2000, pp. 269-269
Huntingtin interacting protein 1 induces apoptosis via a novel caspase-dependent death effector domain
Authors: Hackam, AS Yassa, AS Singaraja, R Metzler, M Gutekunst, CA Gan, L Warby, S Wellington, CL Vaillancourt, J Chen, NS Gervais, FG Raymond, L Nicholson, DW Hayden, MR
Citation: As. Hackam et al., Huntingtin interacting protein 1 induces apoptosis via a novel caspase-dependent death effector domain, J BIOL CHEM, 275(52), 2000, pp. 41299-41308
Inhibiting caspase cleavage of huntingtin reduces toxicity and aggregate formation in neuronal and nonneuronal cells
Authors: Wellington, CL Singaraja, R Ellerby, L Savill, J Roy, S Leavitt, B Cattaneo, E Hackam, A Sharp, A Thornberry, N Nicholson, DW Bredesen, DE Hayden, MR
Citation: Cl. Wellington et al., Inhibiting caspase cleavage of huntingtin reduces toxicity and aggregate formation in neuronal and nonneuronal cells, J BIOL CHEM, 275(26), 2000, pp. 19831-19838
Caspases and neurodegeneration: on the cutting edge of new therapeutic approaches
Authors: Wellington, CL Hayden, MR
Citation: Cl. Wellington et Mr. Hayden, Caspases and neurodegeneration: on the cutting edge of new therapeutic approaches, CLIN GENET, 57(1), 2000, pp. 1-10
Recent insights into the molecular pathogenesis of Huntington disease
Authors: Leavitt, BR Wellington, CL Hayden, MR
Citation: Br. Leavitt et al., Recent insights into the molecular pathogenesis of Huntington disease, SEM NEUROL, 19(4), 1999, pp. 385-395
Kennedy's disease: Caspase cleavage of the androgen receptor is a crucial event in cytotoxicity
Authors: Ellerby, LM Hackam, AS Propp, SS Ellerby, HM Rabizadeh, S Cashman, NR Trifiro, MA Pinsky, L Wellington, CL Salvesen, GS Hayden, MR Bredesen, DE
Citation: Lm. Ellerby et al., Kennedy's disease: Caspase cleavage of the androgen receptor is a crucial event in cytotoxicity, J NEUROCHEM, 72(1), 1999, pp. 185-195
Cleavage of atrophin-1 at caspase site aspartic acid 109 modulates cytotoxicity
Authors: Ellerby, LM Andrusiak, RL Wellington, CL Hackam, AS Propp, SS Wood, JD Sharp, AH Margolis, RL Ross, CA Salvesen, GS Hayden, MR Bredesen, DE
Citation: Lm. Ellerby et al., Cleavage of atrophin-1 at caspase site aspartic acid 109 modulates cytotoxicity, J BIOL CHEM, 274(13), 1999, pp. 8730-8736
Risultati: 1-10 |